Norpel set to launch new processing facility for pet food

Norpel set to launch new processing facility for pet food

Northern Pelagic Group, LLC (NORPEL) announced it will open a new processing facility focused on pet proteins later in 2021.
Royal Canin expands its Lebanon operations in Tennessee

Royal Canin expands its Lebanon operations in Tennessee

Royal Canin, a global player in nutritional health for cats and dogs announces its to expand Lebanon operations in Wilson County, Tennessee.
Covetrus announces the appointment of Deborah Sharkey as CCO

Covetrus announces the appointment of Deborah Sharkey as CCO

Covetrus, a global leader in animal-health technology and services, announced the appointment of Deborah Sharkey as chief consumer officer (CCO).
Purina Pro Plan LiveClear Voted Product of the Year 2021

Product of the 2021: Purina Pro Plan LiveClear

Purina Pro Plan LiveClear was voted Product of the Year 2021. The innovative formula wins in cat care category as first-and-only food that reduces the major allergen in cat hair and dander.
PetPro products transition to Pawru branding

PetPro products transition to Pawru branding

Boehringer Ingelheim Animal Health USA Inc. announced the creation of Pawru, Inc. as a separate Company within the Boehringer Ingelheim Animal Health business. The company's PetPro portfolio will transition to Pawru branding.
PFC Speakers: "Future Is Bright for US Pet Food Industry"

PFC Speakers: “Future Is Bright for US Pet Food Industry”

The American Feed Industry Association (AFIA) wrapped up its 14th annual Pet Food Conference (PFC) on January 26, covering the regulatory and trade outlook for the U.S. pet food sector along with changing consumer trends emerging from the coronavirus pandemic.
Open Farm a premium pet food brand

Open Farm receives $65 million growth investment

Open Farm receives more than $65 million growth investment led by General Atlantic.
Boehringer Ingelheim partners with PetMedix

Boehringer Ingelheim partners with PetMedix

Boehringer Ingelheim announced a multi-year partnership with PetMedix to develop novel and transformative companion animal antibody therapeutics using PetMedix’s proprietary Ky9 platform.